GHG Leadership Team
CURT HUBER – Interim President & CEO, Director
Mr. Huber is an independent corporate consultant who has been involved in all facets of public companies for more than 35 years. He is an experienced director and senior officer who has been involved in the hemp industry since 2014. In addition he has represented public companies in many different sectors, including mining, oil and gas, and technology. He has also provided investor relation services, raised financing in the public markets and built corporate awareness for the companies with which he has been associated.
Connect with Curt Huber
CHRISTOPHER CHERRY, CPA, CA - CFO
Mr. Cherry has over 20 years of corporate accounting and audit experience, along with extensive corporate experience, having held senior level positions for several public mining companies including Director, Chief Financial Officer, and Secretary. He is a CPA having obtained the Chartered Accountant designation in February 2009 and the Certified General Accountant designation in 2004. In his former experience as an auditor, he held positions with KPMG and Davidson and Co. LLP in Vancouver, where he gained experience as an auditor for junior public companies, and an IPO specialist.
AURELIO USECHE, CPA, CMA, MBA – DIRECTOR
Aurelio Useche leverages over 20 years of senior management experience including COO, CFO and CEO in several private and publicly traded corporations in manufacturing, mining exploration, consumer goods and entertainment. Mr. Useche is a CPA, CMA and a graduate of the executive MBA program at Queen’s University School of Business. Mr. Useche is also a graduate of the Corporate Directors program at the University of Toronto’s Rotman School of Business and of the Masters Certificate program in Risk Management program at York University’s Schulich School of Business.
RAMSEY DOUGLAS - DIRECTOR
Ramsey Douglas is a UK professional based in London, whose passion lies in conquering the dynamic challenges of the business world and firmly believes that success in business is a collective effort, driven by the strength of the team.
Since 2017, he became involved in the CBD industry when it was in its infancy in the United Kingdom. Recognizing the need for stability and quality, Mr. Douglas, as Managing Director, spearheaded the World CBD Awards, with the clear mission; identify the world's finest CBD brands through rigorous scientific evaluation and full traceability to the source… MORE
Dr. PAUL T. PERRAULT – Industrial Hemp Advisor
Dr. Perrault is an economist trained in cooperative development (M.A.) and in Rural Development (Ph. D.) (Stanford). After some years of consulting on rural development project in several developing countries, he shifted his career to institutional development. Over the years he participated actively in the creation of several university and training institutions in Rwanda, Nigeria and Côte d’Ivoire. Moreover, he contributed to the strengthening of agricultural research organizations, principally in Africa, as a researcher then as a program director at the International Service for National Agricultural Research (1990-2004), a CGIAR institution. These experiences have shaped his perspective in developing and managing research and education institutions related to agriculture.
LOUIS RENÉ VALLÉE - BUSINESS DEVELOPMENT ADVISOR
Mr. Vallée is a marketing specialist and an expert in brand creation, new product introductions, and positioning of products across retail and wholesale sectors in Canada and the United States.
Mr. Vallee will play a key role is spearheading GHG's business development and marketing efforts for both the Company's Industrial Hemp Division and its Health and Wellness Division. He brings to GHG an impressive network of relationships in the financial, banking and governmental sectors, along with C-Suite contacts to major grocery chains in both Canada and the United States. MORE
MATHIEU COUILLARD - BUSINESS DEVELOPMENT AND CAPITAL MARKETS ADVISOR
Mathieu Couillard is an experienced investment banker who has extensive experience in the cannabis space. He has participated in over $1 Billion in capital raises for cannabis companies from start-ups to some of the largest players in the industry. He is the architect of numerous mergers and acquisitions in his capacity of Managing Director of investment banking at Haywood Securities, leading the Special Situations team from 2016 to 2022.
Prior to joining Haywood Securities, MORE
PROF. VÍCTOR M. CASTAÑO, Ph.D. - ADVISOR, HEAD OF GLOBAL HEMP’S R&D DIVISION
Prof. Castaño is a recognized international leader in several areas of applied science and technology. He has lectured across multiple disciplinary schools in Mexico and was the founding Director of the Center for Applied Physics and Advanced Technology at the National Autonomous University of Mexico (UNAM) in Juriquilla, Querétaro, Mexico. He has published extensively, including 5 books and 25 patents and has received over 14,500 citations in the last few years. He is one of the most cited Latin-American scientists in his area. He is an engineer and scientist who dares to cross disciplinary boundaries.
Prof. Castaño is best known for his work in materials science and biomedicine, where he invented a very extensive line of new materials and technologies for various applications. MORE
NIKOLAS PERRAULT, CFA, CEO TWILIGHT CAPITAL – SPECIAL ADVISOR / CAPITAL MARKETS
Nikolas Perrault is a Chartered Financial Analyst managing Twilight Capital, a capital market advisory consulting firm based in Montreal, which he formed in 2008. Over the last 25 years, Nikolas has built an international network of strategic relationships within the financial markets industry. Nikolas has significant experience in going-public transactions, capital markets, spin-offs and mergers and acquisitions (“M&A”). Previously, Mr. Perrault served as an investment executive with some of Canada's largest institutions. This includes National Bank, Merrill-Lynch, CIBC and Scotia Capital.
DR. STEPHEN D. BARNHILL, MD - SPECIAL MEDICAL ADVISOR
Dr. Barnhill is a Medical Doctor specializing in Cannabinoid and Mycomedicinal Therapeutics, Drug Discovery and Artificial Intelligence, and has completed a Clinical Fellowship in Laboratory Medicine (Clinical Pathology) at the Medical University of South Carolina (MUSC).
Previously, Dr. Barnhill was Founder, Chairman and CEO of both private and public companies, including Founder, Chairman, and CEO of BCL laboratories, LLC with operations in southeastern US, which was acquired by Corning–MetPath now Quest Diagnostics, the largest clinical laboratory in the world. MORE
DR. HERBERT FRITSCHE - CHIEF SCIENTIFIC ADVISOR
Dr. Fritsche is a world-renowned Clinical Chemist and former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas MD Anderson Cancer Center for 41 years.
Dr. Fritsche served as an invited consultant/advisor to the Food and Drug Administration, the National Cancer Institute, the Laboratory Practice Guidelines Committee for the National Academy of Clinical Biochemistry, the Editorial Board of six international scientific journals, and as a consultant to many major international diagnostic companies. Previously, he served on the Expert Panel for developing Tumor Marker Practice Guidelines for the American Society of Clinical Oncology (ASCO) from its inception until his retirement from MD Anderson Cancer Center. MORE
JEFF NAGEL - PRODUCT MANUFACTURING ADVISOR
Jeff Nagel is a veteran in the natural biologics drug discovery and manufacturing space, with more than 15 years’ experience in the industry. He brings with him a wealth of knowledge and expertise that will be invaluable to Global Hemp Group Inc. both as an advisor to the R&D Division in their ongoing development of various hemp-based products and technologies, as well assisting Management in their continuing discussions with various manufacturers and distributors in the sublicensing of its exclusive license of Patents and Intellectual Property. MORE